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ABSTRACT During apoptosis, changes occur in lymphocyte membranes that render them susceptible to hydrolysis by se-
cretory phospholipase A2 (sPLA2). To study the relevant mechanisms, a simpliﬁed model of apoptosis using a calcium
ionophore was applied. Kinetic and ﬂow cytometry experiments provided key observations regarding ionophore treatment: the
initial rate of hydrolysis was elevated at all enzyme concentrations, the total amount of reaction product was increased fourfold,
and adsorption of the enzyme to the membrane surface was unaltered. Analysis of these results suggested that susceptibility
during calcium-induced apoptosis is limited by availability of substrate rather than adsorption of enzyme. Fluorescence
experiments identiﬁed three membrane alterations during apoptosis that might affect substrate access to the sPLA2 active site.
First, intercalation of merocyanine 540 into the membrane was improved, suggesting an increase in lipid spacing. Second,
laurdan detected increased solvation of the lower headgroup region of the membrane. Third, the rate at which ﬂuorescent lipids
could be removed from the membrane by albumin was enhanced, implying greater vertical mobility of phospholipids. Thus, it is
proposed that the membranes of apoptotic cells become susceptible to sPLA2 through a reduction in lipid-neighbor interactions
that facilitates migration of phospholipids into the enzyme active site.
INTRODUCTION
Apoptosis is a complex process involving numerous alter-
ations to components of the nucleus, cytoplasm, and cell mem-
brane (1,2). Changes occurring at the cell membrane include
exposure of phosphatidylserine, ceramide production, mi-
crovesicle shedding, membrane blebbing, loss of membrane
potential, alterations to cytoskeletal attachments, and loss of
membrane integrity (1–9). One of the earliest membrane events
documented thus far is a substantial increase in the action of
secretory phospholipaseA2 (sPLA2) to hydrolyze plasmamem-
brane lipids (9,10).
sPLA2 has been used extensively for studying enzymatic
activity at the water-membrane interface. A key feature of this
enzyme is its ability to distinguish between healthy cells,
which resist hydrolysis by sPLA2, and damaged, necrotic, or
apoptotic cells, which are often susceptible. Studies with
artiﬁcial bilayers have demonstrated that the extent to which
phospholipids are hydrolyzed by the enzyme depends on
speciﬁc physical properties associated with the membrane
(11–17). It has been proposed that analogous properties
also govern the susceptibility of cell membranes (18–21).
A variety of experimental approaches has led to a general
concept in which the action of sPLA2 on the membrane sur-
face involves at least two precatalytic steps (11,12,22–26). In
the ﬁrst step, sPLA2 adsorbs to the membrane surface, and in
the second, an individual phospholipid migrates into the
active site of the enzyme (Scheme 1). In previous studies,
this two-step hypothesis was examined using human eryth-
rocytes as a simpliﬁed model for cell membranes (21). For
those investigations, the apoptotic state of the cell was mim-
icked by treatment with ionomycin, a calcium ionophore. The
resulting calcium inﬂux produced changes in membrane
structure accompanied by increased susceptibility to hydro-
lysis by sPLA2. Analysis of these observations generated the
conclusion that the ability of sPLA2 to attack cell membranes
is determined primarily by the ease of vertical migration of
phospholipids into the active site of adsorbed enzyme (i.e.,
the second step in Scheme 1).
This foundational work from various membrane models
has thus generated a testable hypothesis relating bilayer
structure and sPLA2 activity. The ultimate goal is a complete
understanding of the biophysical and molecular principles
governing this relationship in physiological and pathological
settings such as apoptosis. Accomplishing this goal requires
experiments with nucleated cells. Given the complexities
associated with both apoptosis and cellular models for bio-
physical studies, we sought an experimental system in which
measured effects would be maximized, the relationship be-
tween sPLA2 activity and apoptotic markers would be known,
and links to previous mechanistic studies would be plausible.
Accordingly, S49 lymphoma cells treated with calcium ion-
ophore (ionomycin) were chosen because they meet these
criteria. Ionomycin stimulates rapid apoptosis that appears
synchronized for the majority of the cell population result-
ing in large and reproducible changes in measured events.
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Moreover, as in human erythrocytes, the drug induces
susceptibility to sPLA2 that, in S49 cells, occurs with or
before other major apoptotic changes (9,27).
The monomeric aspartate-49 phospholipase A2 from the
venom of Agkistrodon piscivorus piscivorus was used as the
source of enzyme for several reasons. First, it has been used
extensively in previous mechanistic and structural investi-
gations, including studies with erythrocytes and S49 cells
(9,11,15–21,23,25,27,28). Second, it is easily puriﬁed in large
quantities, making it amenable to biophysical experiments.
Third, it behaves similarly to some of the human isoforms of
the enzyme during ionomycin-stimulated apoptosis (27).
Experiments were designed to examine each of the param-
eters shown in Scheme 1 to assess which is/are involved in
distinguishing resistant cells from those treated with iono-
phore. This assessment was accomplished through measure-
ments and analysis of hydrolysis kinetics, enzyme adsorption,
and membrane structure. The results demonstrated that mod-
ulation of the second step (KE in Scheme 1) accounts for the
increased susceptibility to sPLA2.
MATERIALS AND METHODS
Reagents
The monomeric aspartate-49 phospholipase A2 from the venom of A. p.
piscivoruswas isolated according to the procedure byMaraganore et al. (29).
Ionomycin was purchased from Calbiochem (La Jolla, CA) and dissolved in
dimethylsulfoxide (DMSO) for experiments. The probes Oregon Green 488,
2-(6-(7-nitrobenz-2-oxa-1 3-diazol-4-yl)amino)hexanoyl-1-hexadecanoyl-
sn-glycero-3 phosphocholine (NBD-PC), laurdan, acrylodan-labeled fatty
acid-binding protein (ADIFAB), 1,3-bis-(1-pyrene)propane (bis-pyrene),
diphenylhexatriene (DPH), merocyanine 540 (MC540), and propidium iodide
were acquired from Invitrogen (Carlsbad, CA). Bovine serum albumin (BSA)
was purchased from Sigma (St. Louis, MO). Other reagents were obtained
from standard sources. Probes were dissolved in various solvents as follows:
ADIFAB in 50 mM KCl and 3 mM NaN3, bis-pyrene and DPH in N,N-
dimethylformamide, NBD-PC in ethanol, and all others in DMSO.
Cell culture and experimental protocol
S49 mouse lymphoma cells were grown at 37C in humidiﬁed air containing
10%CO2 and prepared for experiments as described (28). Cell viability aver-
aged 896 6% (standard deviation). For spectral and kinetic experiments, an
aliquot of cells (usually between 0.4 3 106 and 3.0 3 106 cells/ml in modi-
ﬁed balanced salt solution (MBSS)) was then transferred to a quartz ﬂuorom-
eter sample cell and allowed 5 min to equilibrate in the spectroﬂuorometer
(Fluoromax 3, Horiba Jobin-Yvon, Edison, NJ, or PC-1, ISS, Champaign,
IL). Spectral bandpass varied between 4 and 16 nm depending on the in-
tensity of the probe and instrument sensitivity. Data acquisition over time at
multiple wavelengths (ADIFAB, laurdan, and bis-pyrene) was accomplished
by rapid sluing of ﬂuorometer mirrors under control of instrument software.
Temperature and sample homogeneity were maintained as described pre-
viously (19). All experiments and incubations were performed at 37C. For
enzyme adsorption experiments, cells were resuspended inMBSSwith 20 mM
BaCl2 to inhibit sPLA2 hydrolytic activity without preventing adsorption
(26,30,31).
In each procedure where ionomycin was added to cell samples (300 nM
ﬁnal), the experiment was repeated with an equivalent volume of DMSO
(0.25% v/v ﬁnal) to control for the effects of the solvent. A control for direct
effects of ionomycin was also included in assessments of membrane phys-
ical properties (see below).
Membrane hydrolysis
Release of free fatty acids from cell membranes was assayed in real time
with the fatty acid binding protein ADIFAB (excitation, 390 nm; emission,
432 nm and 505 nm). After initiating data acquisition for 100 s, ADIFAB
(65 nM ﬁnal) and ionomycin were added. At 700 s, sPLA2 (0.7–70 nM ﬁnal)
was added and the time course continued for an additional 800 s. Raw data
were quantiﬁed by calculating the generalized polarization (GP) and ﬁtting
to an arbitrary function by nonlinear regression (19). In some cases, hydro-
lysis was assayed by measurement of the rate of propidium iodide (37 mM
ﬁnal) uptake by cells due to the action of sPLA2 as described (28). Previous
experiments have demonstrated that assays with ADIFAB and propidium
iodide give identical results under conditions at which cells are susceptible to
the enzyme’s catalytic activity (28). Thus, the propidium iodide assay was
used only in experiments in which all samples were treated with ionomycin.
Enzyme adsorption
Adsorption of sPLA2 to the cell surface was assayed by ﬂow cytometry with
Oregon Green 488-labeled sPLA2 (L-PLA2). Enzyme labeling was accom-
plished according to instructions provided with the kit (Invitrogen, Carlsbad,
CA). Flow cytometry data were collected using a BD FACSCanto ﬂow
cytometer (BD Biosciences, San Jose, CA) with an argon excitation laser
(excitation 488 nm, longpass 502 nm, bandpass ﬁlter 515–545 nm). Aliquots
of cells (suspended in 1 ml MBSS containing 20 mM BaCl2) were treated
with ionomycin or DMSO for 10 min. For isotherm experiments, varying
amounts of L-PLA2 were then added (0.01–3 mM ﬁnal), and samples were
incubated for an additional 10 min before data acquisition. For competition
experiments, samples were mixed with various concentrations of sPLA2
(0.05–1 mM ﬁnal) for 5 min before adding L-PLA2 (50 nM ﬁnal), and the
incubation was continued for an additional 5 min. Samples were then
immediately processed in the ﬂow cytometer.
Probes of membrane structure
In addition to the ‘‘vehicle control’’ (DMSO), a control experiment was
designed to verify that calcium entry into the cell, rather than artifacts
resulting from direct effects of ionomycin, was responsible for the observed
changes in membrane structure. This control involved incubation of the
sample for at least 200 s with the calcium chelator ethylenediaminetetra-
acetic acid (EDTA) (18 mM ﬁnal; the pH of the EDTA stock was adjusted to
7.6 at 37C to avoid altering sample pH) before addition of ionomycin. In
every case, the results from this ‘‘EDTA control’’ were indistinguishable
from those obtained with the vehicle control. Hence, data from both types of
controls are pooled in the presentation of results.
Data with MC540 (170 nM ﬁnal) were acquired as emission spectra
(excitation, 540 nm; emission, 550–700 nm). Spectra were obtained before
the addition of the probe, after equilibration (5 min), and 10 min after addition
SCHEME 1 Reaction scheme for interaction between sPLA2 and cell
membranes. E, free sPLA2; EB, sPLA2 adsorbed to membrane surface sites
(Ms); S, available substrate (membrane phospholipid); E
s
B, adsorbed enzyme
with substrate bound to the active site; KA, equilibrium constant for enzyme
adsorption to the membrane; KE, equilibrium constant for substrate migra-
tion into the enzyme active site; kcat, turnover number for substrate hydrolysis;
P, product (fatty acid).
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of ionomycin or control reagent(s). Spectra were analyzed by subtracting the
initial spectrum as background and integrating the intensity from 565 to 615
nm. Effects of experimental treatments were quantiﬁed by calculating the
difference in integrated intensity before and after treatment. That difference
was divided by the integrated intensity before treatment to account for
variations in cell number and lamp intensity. Changes in the wavelength of
peak intensity were identiﬁed from derivatives of the spectra.
Laurdan or bis-pyrene ﬂuorescence emission was acquired at dual wave-
lengths in real time. After initiating data acquisition, laurdan (50 nM ﬁnal;
excitation, 350 nm; emission 435 and 500 nm) or bis-pyrene (2.2 mM ﬁnal;
excitation, 344 nm; emission 376 and 480 nm) was added at 100 s. Iono-
mycin or control reagent(s) was/were included after initial equilibration of
cells with the probe (laurdan, 10 min; bis-pyrene, 30 min). The laurdan GP
and bis-pyrene excimer (480 nm)/monomer (376 nm) ratio were calculated
from the data as described (19,32). Background intensity at each wavelength
was subtracted from the data before calculations were made. For two-photon
excitation microscopy of laurdan ﬂuorescence, the concentration was in-
creased to 250 nM to improve image distinction compared to background.
Data for steady-state anisotropy (DPH; excitation, 350 nm; emission, 452
nm) were acquired using Glan-Thompson polarizers in the vertical and
horizontal positions. Data were obtained before the addition of the probe to
measure background cell ﬂuorescence, after 20 min equilibration with DPH
(240 nM ﬁnal), and 10 min after addition of ionomycin or control reagent(s).
Anisotropy was calculated as described (33).
Phospholipid extraction
The ﬂuorescent phospholipid analog, NBD-PC, was suspended in MBSS
immediately before the experiments, as described by Jensen et al. (21). Cell
samples were incubated with ionomycin or control reagent(s) (as in previous
section) for 5 min. NBD-PC (930 nM ﬁnal) was then introduced and allowed
to incorporate into cell membranes (;30 min). After this incubation, cells
were washed to remove excess probe. Data acquisition (excitation, 485 nm;
emission, 535 nm) was then initiated, and BSA (0.7% ﬁnal) was added for
NBD-PC extraction. Apparent extraction-rate constants were obtained by
ﬁtting the ﬂuorescence intensity data after BSA addition to a double expo-
nential decay function by nonlinear regression.
Two-photon excitation scanning microscopy
Scanning two-photon excitation microscopy images were obtained using an
Axiovert 35 inverted microscope (Zeiss, Thornwood, NY) at 37C at the
Laboratory for Fluorescence Dynamics (University of California, Irvine) as
described previously (19,34). Laser emission was 940 nm for NBD-PC and
790 nm for Oregon Green 488. For laurdan (250 nM), dual images were
collected simultaneously using a beam-splitter and interference ﬁlters (Ealing
490 and Ealing 440) with laser emission of 790 nm.
RESULTS
Hydrolysis kinetics
Addition of sPLA2 to S49 cells previously exposed (10 min)
to a control vehicle (DMSO) caused a slight increase in
ADIFAB GP followed by a gradual decline, nearly restoring
the value to its original level (Fig. 1, curve a). This unusual
hydrolysis time course has been shown to represent transient
initial hydrolysis followed by reacylation of the lipids and
reincorporation into the membrane (27). In contrast, prior ex-
posure of cells to ionomycin resulted in a large increase in
ADIFAB GP that quickly reached a stable plateau (Fig. 1,
curve b).
To further characterize hydrolysis kinetics, the experiment
in Fig. 1 was repeated at various enzyme concentrations.
Data were analyzed by nonlinear regression (examples are
shown in Fig. 1). From these phenomenological ﬁts, two
parameters were determined: the initial rate of hydrolysis and
maximum hydrolysis product generated. As displayed in Fig.
2, treatment of cells with ionomycin increased both initial
and total hydrolysis at all enzyme concentrations. The maxi-
mum hydrolysis rate was 0.018 6 0.004 GP units s1 for
DMSO-treated samples and 0.093 6 0.011 GP units s1 for
the ionomycin group. The enzyme concentration at which
the hydrolysis rate was one-half the maximum was 13.5 6
7.8 nM and 9.4 6 3.2 nM, respectively, for the two groups.
Two-way analysis of variance indicated that both the effects
of enzyme concentration and ionomycin treatment on the
initial hydrolysis rate were highly signiﬁcant (p , 0.0001).
A signiﬁcant interaction (p , 0.0001) between the two var-
iables was also observed, suggesting that the magnitude of
the effect of ionomycin depended on enzyme concentration.
The ability of ionomycin treatment to increase total hydro-
lysis product was also signiﬁcant (p , 0.0001).
Enzyme adsorption
Initial attempts to quantify adsorption of sPLA2 to the cell
surface involved a conventional centrifugation assay with
ﬂuorescent-labeled enzyme (L-PLA2), as done previously
with erythrocytes (21). However, control experiments sug-
gested that the observed association of enzyme with the cells
was not reversible. Analysis of microscopy images indicated
that this irreversible interaction reﬂected endocytosis of the
labeled enzyme, a phenomenon previously described for
nucleated cells (35–37).
FIGURE 1 Effects of ionomycin treatment on the time course of mem-
brane hydrolysis by sPLA2. S49 cells were incubated with ADIFAB and
treated for at least 600 s with DMSO (curve a) or ionomycin (curve b) as
explained in Materials and Methods. At the time indicated by the arrows,
sPLA2 (70 nM ﬁnal) was added. Data points represent the raw data (ex-
pressed in GP units), and curves represent nonlinear regression ﬁts of the
data using an arbitrary function consisting of the sum of two exponential
functions. The amount of hydrolysis observed in curve a constitutes;2–5%
of the plasma membrane phospholipid (27).
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Flow cytometry experiments were designed to distinguish
endocytosis of labeled enzyme from reversible adsorption to
the cell surface. Cells were treated with ionomycin or DMSO
for 5 min. All samples were then mixed with L-PLA2, and
half of the samples were washed to remove free enzyme. Fig.
3 displays histograms of L-PLA2 ﬂuorescence intensity per
cell in each of these four groups. Most of the data from
DMSO-treated samples appeared to originate from a single
population of cells (Fig. 3 A). The intensity of this group was
reduced 10-fold (i.e., one log unit along the abscissa) by
washing (Fig. 3 C), suggesting that this peak represented
reversible adsorption of L-PLA2 to the cell exterior. In
unwashed ionomycin-treated samples (Fig. 3 B), at least two
distinct populations were identiﬁed in the histogram of ﬂuo-
rescence intensity. Cells with low ﬂuorescence intensity
(Fig. 3 B, left arrow) accounted for a majority of the sample,
yet they only contributed ;20% of the total ﬂuorescence
signal. The ﬂuorescence of this population was also reduced
10-fold by washing, similar to the DMSO-treated cells (Fig.
3 D, left arrow). In contrast, the high intensity staining was
less affected by washing (Fig. 3, B and D, right arrow),
suggesting that this staining represented internalization of the
enzyme (35–37). This irreversibility corroborated observa-
tions from two-photon microscopy (not shown; see previous
paragraph). Given that reversible surface adsorption is the
relevant phenomenon for interpreting the hydrolysis kinetics,
we focused our analysis on the low-intensity population.
Fig. 4 displays the amount of reversible surface adsorption
of various concentrations of L-PLA2. The average apparent
equilibrium constant for adsorption of L-PLA2 to DMSO-
treated cells was 2.5 3 106 M1. There was no detectable
effect of ionomycin treatment on either the apparent equi-
librium constant (1.73 106 M1, p¼ 0.39) or the maximum
number of adsorption sites per cell (p ¼ 0.20).
To relate these adsorption results to native sPLA2, com-
petition experiments were performed. Unlabeled sPLA2
competed for;30–40% of the L-PLA2 adsorption sites at all
concentrations within the range tested (0.05–1 mM sPLA2
with 50 nM L-PLA2). This result suggested that more than
half of these adsorption sites might not be relevant to hy-
drolysis by sPLA2. The observation that competition was
already maximal when the same concentrations of sPLA2
and L-PLA2 were used (50 nM) indicated that the enzyme
adsorbs more tightly when it is not labeled. This inference is
consistent with the relatively high potency of the unlabeled
enzyme shown in Fig. 2.
FIGURE 2 sPLA2 concentration dependence of the
initial rate of hydrolysis. (A) The experiments of Fig. 1
were repeated at the indicated concentrations of sPLA2 for
cells treated with DMSO (squares) or ionomycin (trian-
gles). The initial rate was deﬁned as the amount of product
generated during 5 s from the time of enzyme addition.
This number was calculated from nonlinear regression ﬁts
of the data, as shown in Fig. 1. Data were analyzed by
two-way analysis of variance to assess the contribution
of sPLA2 concentration (37% of variation, p , 0.0001),
ionomycin treatment (13% of variation, p , 0.0001), and
the interaction between the two (20% of variation, p ,
0.0001). Data points represent the raw data (expressed in
GP units), and curves represent nonlinear regression ﬁts of
the data using an arbitrary function. (B) The total amount
of product after 600 s (or at the maximum for time courses
shaped like that of curve a in Fig. 1) for enzyme con-
centrations $18 nM. The data were signiﬁcant based on
two-tailed unpaired Student’s t-test (p , 0.0001, n ¼ 1–4
at each datum).
FIGURE 3 Reversibility of adsorption of L-PLA2 to
S49 cells. Data represent histograms for Oregon Green
ﬂuorescence intensity obtained by ﬂow cytometry, as
explained in Materials and Methods. (A and B) Cells
were treated with DMSO (A) or ionomycin (B) for 5
min followed by 5 min incubation with 1 mM L-PLA2.
Samples were then transferred immediately to the ﬂow
cytometer. (C and D) The experiments in A (C) and B
(D) were repeated as stated, except that cells were
separated from the supernatant by centrifugation and
washed in fresh MBSS with 20 mM BaCl2 before ﬂow
cytometry. In B and D, the left arrow indicates the low-
intensity, reversible staining of cells with L-PLA2, and
the right arrow indicates the high-intensity staining that
was not removed by washing (explained in Results).
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To better estimate the apparent adsorption constant for
unlabeled sPLA2 (Kapp), we took advantage of control obser-
vations (not shown) demonstrating that L-PLA2 is a weak
enzyme (possessing #1/10 the activity of sPLA2). Accord-
ingly, we repeated the competition experiments using a hy-
drolysis assay at constant sPLA2 concentration (70 nM ﬁnal,
ET in Eq. 1) in the presence of various amounts of L-PLA2
(0.05–20 mM ﬁnal, LT in Eq. 1). The initial hydrolysis rate







We assumed that KL, the adsorption constant for L-PLA2,
was the same at sites of hydrolysis as that estimated for the
entire cell in Fig. 4. Results shown in Fig. 5 provide con-
vincing evidence for competition. Analysis of the data by non-
linear regression estimated that Kapp equals 2.7 3 10
7 M1.
Physical changes in the cell membrane
Previous experiments with erythrocytes revealed several phys-
ical changes in the cell membrane that appeared to explain
the basis for increased susceptibility to the action of sPLA2.
These included increases in the spacing among bilayer lipids,
the average level of lipid order, and the rate at which ﬂuores-
cent phospholipids could be extracted from the cell mem-
brane (21). Similar experiments have been included here to
test the relevance of those ﬁndings to nucleated cells.
Phospholipid spacing
Changes in phospholipid spacing were assessed with
MC540, a probe that intercalates between the phospholipid
heads in the outer leaﬂet of cell membranes (38–40). Treat-
ment of cells with ionomycin resulted in a signiﬁcant in-
crease in MC540 total ﬂuorescence (Fig. 6 A) and a red-shift
in peak wavelength from ;583 to 586 nm (Fig. 6 B), con-
sistent with increased binding of the probe (41). As shown in
Fig. 6, C and D, these effects were reproducible. Control
experiments in which cells were treated with ionomycin in
the presence of a calcium chelator (EDTA) demonstrated that
these effects were due to calcium inﬂux rather than repre-
senting artifacts caused directly by the presence of ionomycin
in the membrane. Since EDTA controls were indistinguish-
able from DMSO-treated samples, data from both types of
controls were pooled in the presentation of results for MC540
and all other probes of membrane physical properties (see
legends to Figs. 6–9). These spectral changes in MC540 ﬂuo-
rescence suggest that treatment with ionomycin increased the
spacing among membrane phospholipids.
Membrane order
Three ﬂuorescent probes were used to examine the relation-
ship between susceptibility and membrane order. Laurdan
FIGURE 4 Concentration dependence of L-PLA2
adsorption to S49 cells. (A) The experiments of Fig. 3,
A and B, were repeated at the indicated concentrations
of L-PLA2. The amount of adsorbed L-PLA2 was
estimated from the ﬂuorescence intensity represented
by the mode of the low-intensity peak in the ﬂow
cytometry histograms (e.g., as indicated in Fig. 3 B (left
arrow)). Data (squares, DMSO; triangles, ionomycin)
were ﬁt by nonlinear regression to a standard Langmuir
binding isotherm function. (B) Values for an apparent
adsorption constant (KL) and the maximum adsorption
at saturation (Amax) were obtained from ﬁts such as
those shown in A for four independent experiments.
The data for DMSO and ionomycin-treated samples
were compared by two-tailed paired Student’s t-test.
Adsorption constant: p ¼ 0.39; maximum adsorption:
p ¼ 0.20. Data are expressed as mean 6 SE.
FIGURE 5 Ability of L-PLA2 to interfere with cell membrane hydrolysis
by sPLA2. Cells were treated for 400 s with ionomycin and then subjected to
hydrolysis by 70 nM sPLA2. Hydrolysis was assayed using propidium
iodide (see Materials and Methods). The relative hydrolysis rate was
calculated as the inverse of the half-time for uptake of propidium iodide by
the cells (28). The experiment was repeated in the presence of the indicated
concentrations of L-PLA2. The data were ﬁt by nonlinear regression to
Eq. 1 as described in Results.
2354 Bailey et al.
Biophysical Journal 93(7) 2350–2362
intercalates at the level of the glycerol backbones (42). The
shape of laurdan’s emission spectrum is highly sensitive to
the solvent relaxation effect and is quantiﬁed as GP (see
Materials and Methods). GP varies between 1.0 and 1.0
and has been interpreted to reﬂect the degree to which lipid
molecules are ordered within the membrane (a value of 1.0
denotes a highly ordered membrane in which no solvent
relaxation occurs (32,33)). Bis-pyrene has traditionally been
used to evaluate the level of ‘‘ﬂuidity’’ in the membrane,
implying the ability of molecules to diffuse laterally along
the bilayer plane (43). More recent experiments exploring
the phosphatidylcholine/cholesterol phase diagram indicated
that the probe is more sensitive to phospholipid acyl chain
order (44). Presumably, bis-pyrene resides deep in the mem-
brane, based on the partitioning of the parent compound,
pyrene (45). Diphenylhexatriene also locates deep in the
membrane (46). The anisotropy of DPH is sensitive to both
ﬂuidity (which alters the rotational diffusion rate of the
probe) and environmental constraints imposed by the level of
chain order (44,47).
Laurdan GP before and after treatment with ionomycin
and subsequent controls is illustrated in Fig. 7. In Fig. 7 A,
laurdan GP over time is displayed. Ionomycin (added at
arrow) caused GP values to decrease until it reached a min-
imum 10 min after treatment. This effect was signiﬁcant
(Fig. 7 B). Images collected by two-photon microscopy
veriﬁed that the changes reported in Fig. 7 B were conﬁned
to the plasma membrane (Fig. 7, C–F). In contrast, no dif-
ferences in apparent lipid order were identiﬁed with either
bis-pyrene excimer/monomer ratio or DPH steady-state
anisotropy (Fig. 8).
Phospholipid extractability
Changes in the propensity of phospholipids to migrate ver-
tically in the bilayer were estimated by extraction experi-
ments utilizing NBD-PC, a ﬂuorescent phospholipid analog
that inserts into lipid bilayers (21,48). We used the protein
BSA as a lipid acceptor in these experiments. This protocol
allowed us to estimate the rate of extraction. As shown in
Fig. 9 A, time courses of NBD-PC ﬂuorescence after BSA
addition were ﬁt to a two-phase exponential decay (with t ¼
0 corresponding to the time of BSA addition), with a rapid
initial drop in intensity followed by a gradual decline. An
overall rate constant was derived from the regressions and
compared for multiple samples (Fig. 9 B). Ionophore treat-
ment generated a reproducible twofold increase in the rate of
NBD-PC extraction.
Initial and ﬁnal ﬂuorescence intensities often differed
between DMSO- and ionomycin-treated samples (generally
greater in the ionophore group, not shown). For this reason,
the data in Fig. 9 A are normalized. We used ﬂow cytometry
and two-photon microscopy to address the possibility that
intensity differences reﬂected artifacts (due to the extent of
extraction and/or labeling) that might interfere with our
analysis. Flow cytometry experiments demonstrated that the
amount of ﬂuorophore removed by BSA was comparable
between control and treatment groups (89% and 85%, respec-
tively (not shown)). Two-photon microscopy images re-
vealed that it was common for cells to display labeling of
internal compartments in addition to the plasma membrane
(more prominent in ionomycin-treated cells; example shown
in Fig. 9, C–E). Upon BSA addition (between Fig. 9, C and
D), ﬂuorescence intensity decreased quickly from the peri-
meter of the cells and more gradually from the interior (Fig. 9
D, 2 min after addition; Fig. 9 E, 4 min after addition). These
experiments convinced us that at least the initial rapid decay
of ﬂuorescence intensity, dominant in the analysis shown in
Fig. 9, A and B, could reasonably be interpreted to represent
lipid extraction from the cell membrane.
DISCUSSION
The purpose of this study was to identify how changes in the
cell membrane induced by calcium ionophore treatment might
increase the rate of phospholipid hydrolysis by extracellular
sPLA2. To this end, the model shown in Scheme 1 was used
to analyze the results of the kinetic experiments displayed
in Fig. 2. The initial rate of lipid catalysis (dP/dt) is given by
FIGURE 6 Effects of ionomycin treatment on MC540 ﬂuorescence. (A)
Representative emission spectra showing the intensity of MC540 bound to
S49 cells before (solid curve; labeling details explained in Materials and
Methods) and 10 min after ionomycin addition (dashed curve). (B) Spectra
displayed in A were normalized to their respective maximum intensities. (C
and D) The change in MC540 ﬂuorescence intensity (C) (quantiﬁed as
described in Materials and Methods) and shift in wavelength of emission
maximum (D) were compared for controls (vehicle and EDTA controls; see
Materials and Methods) and ionomycin-treated samples by two-tailed
unpaired Student’s t-test. Data are expressed as mean6 SE. p, 0.0001 (C);
p ¼ 0.005 (D); n ¼ 6 (controls) or 3 (ionomycin).
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where b is proportional to kcat and the total number of
adsorption sites for the enzyme (ET) (21). It is assumed that b
does not change with experimental treatment because altera-
tions to membrane structure would presumably affect reac-
tion steps preceding the catalytic event (see Jensen et al. (21)
and discussion below). For simplicity, b is assigned a value
of 1.0 GP units s1. ST represents the mole fraction of mem-
brane phospholipids available to the enzyme. In previous
analyses, it has not been considered separately from KE since
the two parameters are completely linked in the model (see
Eq. 2 and Jensen et al. (21)). However, the data of Fig. 2 B
demonstrate that ST is subject to change upon experimental
treatment and provide information to quantify the magnitude
of that change. ST is therefore included speciﬁcally as a
parameter in Eq. 2 and expressed in relative units (i.e., it is
assigned a value of 1.0 under control conditions).
As shown in Fig. 10 A, the control data from Fig. 2 A were
well ﬁt by Eq. 2. The value of KA (6.7 3 10
7 M1) matched
favorably the value estimated from competition with L-PLA2
(2.7 3 107 M1 in Fig. 5). The effect of ionomycin on the
initial hydrolysis rate was evaluated by considering ST, KA,
and KE individually in the ﬁt to identify the minimum criteria
required by the results (parameter values summarized in
Table 1). The data of Fig. 2 B indicated that ST increased by a
factor of;4.4 with ionophore treatment. Accordingly, Eq. 2
was recalculated maintaining all parameter values from the
ﬁt of the control data with the exception of ST. The 4.4-
fold increase, however, was insufﬁcient to account for the
ionomycin data (Fig. 10 B). In fact, a reasonable ﬁt was
obtained only with a much larger (8.1-fold) increase in ST,
one that cannot be justiﬁed based on the data of Fig. 2 B (Fig.
10 C). Since KE and ST are linked in Eq. 3, the dilemma can
obviously be resolved by increasing KE by a factor of 1.8 in
FIGURE 7 Effect of ionomycin on laurdan GP. (A)
Cells labeled with laurdan were treated without (curve a,
vehicle control) or with (curve b) ionomycin (arrows). (B)
For each experiment, 30 points before treatment with
ionomycin were averaged and pooled in the ‘‘Before’’
group (n ¼ 12). ‘‘Controls’’ (n ¼ 6) and ‘‘Ionomycin’’
(n ¼ 6) groups represent the average of 30 points after
stabilization of the ﬂuorescence signal. Data are expressed
as mean 6 SE and analyzed by one-way analysis of
variance with Bonferroni’s Multiple Comparison Post Test
(p , 0.0001 overall; Before versus Controls: p . 0.05;
Before versus Ionomycin: p , 0.001; Controls versus
Ionomycin: p, 0.001). (C–F) Two-photon images of S49
cells were collected before and after incubation with
ionomycin in the absence or presence of EDTA (as a
control): (C) EDTA; (D) EDTA 1 ionomycin; (E) normal
calcium; (F) normal calcium1 ionomycin. In each image,
the left half displays a broad range of GP values from –0.1
(white) to 0.62 (dark gray), and the right half displays the
same image with a basement threshold of 0.1, so that only
pixels corresponding to high GP values are shown.
FIGURE 8 Effect of ionomycin on bis-pyrene and DPH ﬂuorescence. (A)
Time course of bis-pyrene excimer/monomer ratio; ionomycin was added at
the arrow. (B) Cells were labeled with DPH as explained in Materials and
Methods, and anisotropy measurements were obtained before (n ¼ 10, all
samples pooled) and after treatment with control reagent(s) (n ¼ 6) or iono-
mycin (n ¼ 4). Data are expressed as mean 6 SE and were not signiﬁcant
based on one-way analysis of variance (p ¼ 0.61).
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addition to a ﬁxed 4.4-fold increase in ST (Fig. 10 D). Alter-
natively, allowing KA to vary instead of KE was inadequate
to accommodate the data (Fig. 10 E). The best ﬁt, of course,
was obtained when both KA and KE were allowed to ﬂoat in
combination with the prescribed increase in ST (Fig. 10 F).
This ideal ﬁt corresponded to a twofold increase in KE (in
strong agreement with that of Fig. 10 D) coupled with a
reduction in KA by;16% (corroborating the result in Fig. 10
E). Thus, we concluded from this analysis that increased
susceptibility after ionomycin treatment has little or nothing
to do with the strength of adsorption (KA) and can be ex-
plained entirely by increases in the accessibility of lipids to
the enzyme active site (KE and ST).
It is important to note that the differences between control
and treatment curves in Fig. 2 A could easily be explained by
adjustments to kcat. Variations in kcat could be due to either
cofactor availability or enzyme conformational change. Since
the same medium was used in all data sets, availability of the
cofactor calcium was not an issue. Moreover, if changes in
membrane microstructure stabilized the transition to an ac-
tivated enzyme conformation, that stabilization would be
reﬂected by enhanced adsorption of sPLA2 to the membrane
surface. Although multiple conformations of sPLA2 have
indeed been observed and may be linked to adsorption and/or
substrate binding (49), we have no evidence that adsorption
of the enzyme is altered by ionomycin. Therefore, it is
unlikely that conformational transitions are affected by iono-
phore treatment, and our use of a constant value for kcat (i.e.,
the parameter ‘‘b’’ in Table 1 and Eq. 2) is appropriate.
It may seem surprising that the afﬁnity of the enzyme to
adsorb to the membrane surface (KA) was not altered by
ionomycin treatment (Fig. 4). It is well established that
calcium inﬂux promotes exposure of anionic phosphatidyl-
serine on the outer surface of the cell membrane (50,51). In
previous studies with ionophore-treated S49 cells, this lipid
ﬂip-ﬂop occurred as early as could be detected and cor-
responded temporally with increased susceptibility to sPLA2
activity (9). Moreover, the presence of anionic lipids greatly
promotes sPLA2 adsorption in artiﬁcial bilayers and cells
(11,52–54). Since much of the adsorption of labeled-sPLA2
observed in Fig. 4 appeared unrelated to membrane hydro-
lysis (for example, binding to heparin sulfate (55)), it could be
argued that the methods employed to assess KA were inca-
pable of discerning relevant changes. For this reason, we
applied the kinetic analysis detailed in Fig. 10, which sub-
stantiated the idea that differential membrane susceptibility
is not determined by variation in enzyme adsorption. Further-
more, experiments in human erythrocytes with an inhibitor
of phosphatidylserine translocation supported the conclusion
that exposure of anionic lipids was not a requirement for
enhanced hydrolysis upon ionomycin treatment (9,18). This
view is supported by studies indicating that apoptotic stimuli
other than ionomycin induced sPLA2 susceptibility before
phosphatidylserine exposure in S49 cells (9). Overall, these
ﬁndings suggest that transbilayer movement of speciﬁc phos-
pholipids does not necessarily provide a preferred substrate
for the enzyme, nor is ﬂip-ﬂop the primary determinant of
membrane vulnerability to sPLA2. Nonetheless, loss of mem-
brane asymmetry could possibly alter other properties of the
phospholipid bilayer, which then render the membrane sensi-
tive to sPLA2 activity. For example, exposure of phospha-
tidylserine could contribute to the increased lipid spacing we
observed (56).
A caveat to the conclusion that increased membrane sus-
ceptibility to sPLA2 does not result from enhanced enzyme
adsorption and/or ﬂip-ﬂop of phosphatidylserine is the fact
that the experiments reported here were conducted with en-
zyme puriﬁed from snake venom. Several isoforms of sPLA2
FIGURE 9 Effect of ionomycin on the rate of NBD-PC
extraction by BSA. (A) Time course of NBD-PC ﬂuores-
cence in samples treated with ionomycin (gray) or control
reagent(s) (black) with t ¼ 0 corresponding to the time
of BSA addition. Data points are normalized to the maxi-
mum and minimum ﬂuorescence intensity, and curves are
two-phase exponential decay ﬁts. (B) The rate constant
obtained from these ﬁts for controls (n ¼ 7) and
ionomycin-treated (n ¼ 5) samples were compared by
two-tailed unpaired Student’s t-test. Data are expressed as
mean 6 SE (p ¼ 0.003). (C–E) Two-photon images of an
S49 cell labeled with NBD-PC and treated with ionomycin
(C) before, (D) 2 min after, and (E) 4 min after addition of
BSA.
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have been identiﬁed which differ in their intrinsic catalytic
activity (kcat), their afﬁnity for membrane surfaces, and their
dependence on the presence of anionic lipids (57). Thus, the
degree to which phosphatidylserine exposure and potential
differences in KA contribute to the level of membrane hydro-
lysis under different experimental or physiological conditions
may well depend on the isoform in question. Nevertheless,
in previous experiments, human groups IIa and V sPLA2
species displayed behavior toward S49 cells that was
qualitatively identical to that observed with the snake venom
enzyme (27). Therefore, although quantitative differences
exist among various sPLA2 types, the concept that substrate
availability contributes, at least in part, to the level of mem-
brane susceptibility probably applies to all of them.
Structural evidence suggests that sPLA2 acts at the mem-
brane surface with its active site displaced physically from
the position normally occupied by bilayer phospholipids
(24). If this is true, substrate availability (ST) represents the
number of lipids capable of making a vertical movement
from their normal position, which, according to the results
(Fig. 2 B), increases during a sustained calcium inﬂux. More-
over, the larger value of KE required to ﬁt the data indicates
that this vertical transition also occurs more easily.
We focused our analysis primarily on the initial rate of
hydrolysis to avoid concerns about latent hydrolysis of in-
ternal bilayers such as the perinuclear membrane (36,37). Of
course, measurement of total hydrolysis would include any
internal hydrolysis product generated during the 10-min time
frame of the experiment (see Fig. 2 B), especially with
ionomycin treatment, which promoted internalization of
L-PLA2 (see Fig. 3 B). Therefore, it may be unreasonable
to include the full measured value of ST in the analysis with
Eq. 2. The observation that the majority of total hydrolysis to
be accomplished is complete within;50 s (Fig. 1) mitigates
this concern since this timescale is shorter than that reported
for internalization (36,37). Based on the linkage of KE and ST
in Eq. 2, overestimation of ST corresponds to underestima-
tion of KE; thus, changes in KE may be greater than we
assumed in the analysis shown in Fig. 10 and Table 1.
Regardless of the relative contributions of those two param-
eters to the effect of ionomycin on the initial rate, the argu-
ment that the membrane properties have changed to facilitate
availability of substrate (either kinetically, KE, or physically,
ST) to the active site of the enzyme is still valid. Obviously,
the mechanistic basis for increased ST in the presence of
ionomycin requires additional investigation.
What could account for the increase in substrate access to
the enzyme? The ﬂuorescence of three of the ﬁve membrane
probes we examined changed reproducibly due to ionophore.
For example, MC540 bound more easily to the membrane,
and laurdan emission was red-shifted, consistent with in-
creased penetration of water molecules into the bilayer. These
two observations suggest that the membrane surface had be-
come more accommodating to intercalation of contaminating
molecules from the aqueous phase. This result, together with
an enhanced rate of NBD-PC extraction from the outer leaﬂet
of the cell membrane, implies that the strength of interaction











A 1.0 0.067 0.10 1.0
B 1.0 0.067 0.10 4.43
C 1.0 0.067 0.10 8.12
D 1.0 0.067 0.18 4.43
E 1.0 0.273 0.10 4.43
F 1.0 0.056 0.20 4.43
Parameter values were obtained by nonlinear regression using Eq. 2, as
explained in the legend to Fig. 10. Values allowed to ﬂoat in the regression
are in bold print.
FIGURE 10 Analysis of hydrolysis results in terms of Scheme 1. Initial
sPLA2 hydrolysis rates from Fig. 2 A were ﬁt by nonlinear regression to
Eq. 2 multiple times with various combinations of constraints. (A) Baseline
parameter values were obtained by ﬁtting the control (DMSO) data from Fig.
2 A; parameter values are listed in the ﬁrst row of Table 1. Some parameters
were allowed to ﬂoat in ﬁts of the ionomycin data (B–F), as detailed below.
ST was ﬁxed at 1.0 GP units in A and at 4.66 GP units with the ionomycin
data (except in C), as explained in the text. The remaining parameters were
kept ﬁxed at the values obtained in A (details in Table 1, rows 2–6). The
parameters allowed to ﬂoat during the ﬁts for each panel were: (B) no
parameters, (C) ST, (D) KE, (E) KA, and (F) KE and KA.
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among neighboring phospholipids is diminished by calcium
inﬂux. With the loss of favorable interactions coupled with
increased hydration of the bilayer, the hydrophobic active
site of the enzyme would presumably become a more attrac-
tive alternative to the membrane, thus enhancing the proba-
bility of hydrolysis.
Another possible explanation for the laurdan ﬂuorescence
relates to phospholipid chain dynamics. Many studies have
suggested that changes in solvent access to laurdan correlate
with the level of phospholipid chain order (32,33,58–60).
The experiments conducted with bis-pyrene and DPH al-
lowed us to examine whether such was the case here, since
both probes are sensitive to the order of their environment
(44). Interestingly, neither probe detected any change asso-
ciated with ionomycin treatment. Therefore, the average
level of phospholipid chain order in the membrane appeared
to remain stable during calcium inﬂux, and our interpretation
of laurdan ﬂuorescence relating to hydration changes at the
membrane surface appears more plausible.
Initially, it may seem counterintuitive to propose that dis-
ruptive alterations have occurred that can be detected readily
at the membrane surface without removing constraints on
probe motion deep in the bilayer. One possibility is that iono-
phore treatment has generated local regions of high curvature
stress in the membrane causing an increase in headgroup
spacing simultaneous with crowding of the chains. Since
phospholipid micelles are excellent substrates for sPLA2
(61), such local curvature could explain the various obser-
vations in this report. We also note that changes in lipid spacing
can occur without accompanying alterations in lipid order
and/or lipid ﬂuidity within liquid-ordered phases in both
erythrocytes and artiﬁcial membranes (44).
This result (alterations at the surface with no change in
chain order) contrasts observations from erythrocytes in which
treatment with ionomycin actually increased the average
lipid order of the membrane (18–20). Two distinctions be-
tween erythrocytes and lymphocytes are helpful in under-
standing this difference. First, susceptibility to hydrolysis
upon ionophore treatment is about six times greater in lym-
phocytes than in erythrocytes (compare data in Fig. 2 to
Smith et al. (18)). Logically, one would expect that mem-
brane changes relevant to hydrolysis would also be more
prominent in S49 cells. Changes observed in laurdan GP and
MC540 ﬂuorescence intensity were enhanced by factors of
;10 (in the opposite direction) and 70, respectively, fulﬁll-
ing this criterion (compare data in this report with raw data
used in Best et al. (20) and Jensen et al. (21)). Second, micro-
scopic images of erythrocytes revealed that ionomycin-
induced alterations in lipid order were conﬁned to speciﬁc
membrane domains (18,20). In general, membrane domains
in nucleated cells are much smaller than those of erythrocytes
(62), making it unlikely that similar observations of increased
order in discrete domains would be possible in lymphocytes,
especially against the background of a more pronounced
membrane hydration described above. Nevertheless, it is im-
portant to note that the data described for erythrocytes led to
the same conclusion as that inferred here: that increased sus-
ceptibility to enzyme hydrolysis is precipitated by a reduction
in the strength of lipid-neighbor interactions.
A major remaining question is the means by which iono-
phore treatment produces membrane changes responsible for
elevated sPLA2 activity. Resolution of this matter will
require genetic and biochemical approaches beyond the
scope of this study. Nevertheless, possible candidates may be
identiﬁed from existing reports. The fact that cells rapidly
become susceptible to sPLA2 (i.e., within 10 min) during
ionomycin-induced apoptosis helps evaluate the possibilities
and exclude those events that arise too late (9). One obvious
candidate for linking known apoptotic events with mem-
brane sensitivity to sPLA2 is the exposure of phosphatidyl-
serine. As discussed above, this event appears unable to
explain the increase in membrane hydrolysis, at least for the
snake venom enzyme. Membrane blebbing and loss of in-
tegrity can also be eliminated as major contributing factors,
because these events occur much later than the onset of sus-
ceptibility (9). The images in Figs. 7 and 9 corroborate the
observation with respect to blebbing. The sustained loss of
membrane potential associated with ionophore- and hormone-
induced apoptosis in lymphocytes also appears to occur on a
timescale well beyond that relevant to the phospholipase
(3,5).
Ceramide accumulation, through de novo synthesis and
cleavage of sphingomyelin, is well established as a partic-
ipant in apoptotic signaling pathways (2). Furthermore, it has
been suggested that sphingomyelin inhibits sPLA2, and that
its removal could therefore promote increased activity of the
enzyme (63,64). The details of ceramide’s role in apoptosis
vary among cell types (2) and have not yet been characterized
in S49 cells. Nonetheless, in prior experiments, treatment of
S49 cells with sphingomyelinase did not enhance sPLA2
activity (27).
In addition to blebbing, apoptotic cells sometimes shed
smaller pieces of the plasma membrane known as micro-
vesicles. Such is the case with ionomycin-stimulated S49
cells (27). This microvesiculation appears to be facilitated by
both phosphatidylserine exposure and cytoskeletal cleavage,
and the vesicles released are susceptible to the enzyme
(18,63,65–68). These observations raise the question of whether
the increase in membrane susceptibility reﬂects direct
hydrolysis of the plasma membrane or, instead, degradation
of released microvesicles. This issue has been addressed
extensively in studies of human erythrocytes and S49 cells.
In both cases, the conclusion was reached that although
microvesicles are attacked by the enzyme, they represent a
minor fraction of the total hydrolysis, with the remainder
occurring in membranes associated with the cells (18,27).
Cytoskeletal alterations are more likely candidates for
apoptotic events that might alter the membrane’s response to
sPLA2 (6–8). Given the sensitivity of various membrane
properties to cytoskeletal structure during apoptosis (6), it is
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reasonable to speculate that the same may be true for the
response to sPLA2. For example, membrane tension could be
highly important in determining the access of lipids to the
enzyme active site (22) and certainly would be affected by
the arrangement and number of cytoskeletal attachments. Like-
wise, cytoskeletal elements may regulate the lateral distri-
bution of membrane lipids. Disruption of domain structure
upon cytoskeletal rearrangement could free additional sub-
strate for catalysis that previously was inaccessible to the
enzyme (thus, the increase in ST).We are now initiating genetic,
pharmacological, and histological studies to explore these
interesting possibilities as well as the relationship to other
membrane events discussed here.
The long-term goal of this line of research is an under-
standing of the relationship between cell membrane structure
and the differential activity of sPLA2 in physiological set-
tings. To that end, this report applies the model of sPLA2
action developed by multiple researchers (see Scheme 1) to
nucleated cells to test hypotheses derived from erythrocyte
studies. Erythrocytes were employed in those prior studies
because they offer a simpliﬁed, quasicellular model devoid
of certain experimental complications, such as probes binding
to intracellular membranes. Fortunately, we were able to
address these complications here using ﬂow cytometry and
two-photon microscopy to assist in the interpretation of the
data (see Results). The move to lymphocytes was a meaning-
ful step toward a biologically relevant system in which sus-
ceptibility to sPLA2 occurs during physiological processes
such as apoptosis. Most important, we have demonstrated
means by which biophysical techniques and information
regarding membrane-protein interactions can be applied to
studies of nucleated cells. The next step will be to resolve the
timing of the membrane changes described in this report with
respect to both the level of sensitivity to sPLA2 and other
events during hormone-stimulated apoptosis.
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